[
    [
        {
            "time": "",
            "original_text": "港股收评：恒指收跌1.23% 医药股逆势上涨",
            "features": {
                "keywords": [
                    "恒指",
                    "收跌",
                    "医药股",
                    "逆势上涨"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股收评：恒指收跌1.23% 医药股逆势上涨",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "上海医药:主业稳健增长,整合发挥集团优势",
            "features": {
                "keywords": [
                    "上海医药",
                    "主业",
                    "稳健增长",
                    "整合",
                    "集团优势"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药:主业稳健增长,整合发挥集团优势",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业17年报18年一季报总结:增速回升,内部分化,关注创新、优质仿制药、连锁药店、医药商业",
            "features": {
                "keywords": [
                    "医药生物",
                    "增速回升",
                    "内部分化",
                    "创新",
                    "优质仿制药",
                    "连锁药店",
                    "医药商业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业17年报18年一季报总结:增速回升,内部分化,关注创新、优质仿制药、连锁药店、医药商业",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]